Cardiac Surgery


Clinical activity

The Cardiac Surgery Unit deals in particular with the treatment of  ischemic cardiac diseases by bypass myocardial revascularisation, mitral and aortic valvulopathies by valve replacement or valvuloplasty (conservative intervention), aortic aneurysms by open or endovascular treatment.

Thanks to modern technologies, coronary surgery procedures may be performed on a beating heart (off pump coronary artery bypass-OPCAB), which is a safe and proven option to conventional bypass surgery.    Doing surgery on a beating heart eliminates the need for the heart-lung machine. This can result in fewer side effects. Finally, where possible, we tend to favour revascularisation by using only arterial ducts (internal mammary artery, radial artery).

Mitral and aortic valvulopathies are treated   with both conservative techniques (valvuloplasty) and replacement by biological or mechanical valve prostheses. Some operations are performed with minimally invasive techniques, without leaving noticeable scars in the chest area.

The stenotic pathologies of the aortic valve, in selected cases, are treated with the Transcatheter Aortic Valve Implantation. This minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. The surgery may be called a transcatheter aortic valve replacement (TAVR) or transcatheter aortic valve implantation (TAVI).  This new technique allows the surgeon to gain access to the heart without opening the chest.

Thoracic aortic aneurysms are addressed and resolved with a range of procedures: from isolated tubular replacement to the combined aortic valve repair and replacement procedures (like Tirone David, Yacoub , Bentall,). Repair of the aneurysm of the aortic arch is done both in the     traditional way (Dacron tube implantation)  and by the use of hybrid techniques (debranching and endovascular prostheses with mixed approach).

The surgical treatment of the aneurysm involving the ascending aorta   is associated with a complication rate of less than 2 percent and represents a point of excellence for the Unit.

All other adult heart diseases (congenital malformations, mixoma, fibroelastoma, defects of the interatrial septum and the interventricular septum) are also treated.

In the arrhythmology field, the Cardiac Surgery Unit uses minimally invasive and conservative techniques for surgical therapy of  atrial fibrillation.

In summary, what the Cardiac Surgery Unit offers:

  • Coronary Artery Bypass Surgery – including high risk Coronary Artery Bypass Surgery,
  • Off Pump Bypass Surgery
  • Heart Valve Surgery
  • Balloon Mitral Valvotomy
  • Heart Valve Disease – Percutaneous Interventions
  • Minimally Invasive Mitral Valve Repair
  • Mitral Valve Repair
  • Surgery for Infective Endocarditis
  • Tricuspid Valve Surgery
  • Minimally Invasive Heart Surgery
  • Surgical treatment for Atrial
  • Surgery for Aorta Surgery, Marfan Syndrome, and Connective Tissue Disorders
  • Complex Aorta Surgery
  • Surgery for Hypertrophic Cardiomyopathy
  • Adult Congenital Heart Surgery

Our advanced diagnostic tools, treatments, and educational programs allow us to provide complete and innovative cardiovascular and thoracic care. Our team of specialists takes a personalized approach to cardiac care, evaluating every patient’s unique circumstances, preferences, and goals to determine the most appropriate intervention to treat their heart disease and improve their health.

Latest Advances

Hybrid Revascularizations

Hybrid revascularization is a combination of coronary artery bypass surgery and percutaneous coronary intervention (PCI). It is also available to you at Campus BioMedico.

All services are available under both regional public and private practice.

Research fields

  • Tissue engineering and cell therapies aimed at repairing or replacing cardiac and vascular tissues
  • Pharmacological effects on inflammatory mechanisms caused by cardiac surgery
  • Endothelial reactivation of the ducts used for the insertion of coronary bypass
  • Conservative mitral valve surgery

Clinical and research collaboration

  • Cardiac and Molecular Biology Laboratory, University of Pittsburgh Medical Center (USA)
  • Department of Cardiac Surgery, University of Navarre, Pamplona (Spain)
  • Department of Biochemical Sciences, Sapienza University of Rome
  • Department of Cardiac Surgery, North Cardiological Centre of Saint-Denis, Paris (France)
  • Department of Cardiothoracic Surgery, Golden Jubilee National Hospital, Glasgow (United Kingdom)